Filed: 5/15/2023ACC: 0000905148-23-000447
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $180.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$180.42M
Total AUM (reported)
19.94M
Total Shares
Allocation by class
COM$180.42M100.0%
Portfolio Concentration
Top 3$154.66M85.7%
4–10$25.76M14.3%
Top 3 weight
85.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 19.94M
Sole
Full voting authority
19.94M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
VENTYX BIOSCIENCES INC
SOLEShares2.30M
TypeSH
Market value$77.01M
42.68%
Sole
2.30M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$43.84M
24.30%
Sole
9.70M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares1.04M
TypeSH
Market value$33.81M
18.74%
Sole
1.04M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares2.28M
TypeSH
Market value$18.35M
10.17%
Sole
2.28M
Shared
0.00
None
0.00
IMPEL PHARMACEUTICALS INC
SOLEShares2.76M
TypeSH
Market value$3.86M
2.14%
Sole
2.76M
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares1.87M
TypeSH
Market value$3.55M
1.97%
Sole
1.87M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VENTYX BIOSCIENCES INCSOLE | COM | 2.30M | SH | $77.01M 42.68% | 2.30M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $43.84M 24.30% | 9.70M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 1.04M | SH | $33.81M 18.74% | 1.04M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 2.28M | SH | $18.35M 10.17% | 2.28M | 0.00 | 0.00 |
IMPEL PHARMACEUTICALS INCSOLE | COM | 2.76M | SH | $3.86M 2.14% | 2.76M | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 1.87M | SH | $3.55M 1.97% | 1.87M | 0.00 | 0.00 |